for linkage with markers in the region of SUR1, indicating that it was not a major NIDDM susceptibility gene in these populations (6, 7) . We have tested eight markers spanning a 31-cM region of chromosome 11 band Ilpl5.1-pl4, which includes SUR1, the linked Kir6.2 gene, and the human homolog of the murine obesity locus tubby (8, 9) , for linkage with NIDDM in a group of 159 non-Hispanic white affected sib pairs.
Patients were defined as having NIDDM according to the criteria of the World Health Organization or the National Diabetes Data Group (10) . Only subjects with onset of NIDDM after 35 years of age were included. Informed consent was obtained from all subjects before testing. These studies were approved by the University of Chicago Institutional Review Board and by the University Clinic Carl Gustav Carus Dresden Ethics Committee. The Dresden group was ascertained through the diabetes clinic of the Department of Internal Medicine in (University Clinic Carl Gustav Carus Dresden) and consisted of 200 individuals from 96 families, for a total of 113 affected sib pairs. The Chicago group was ascertained through the diabetes clinic at The University of Chicago clinics and hospitals and consisted of 69 individuals from 31 families, for a total of 46 affected sib pairs. The combined group consisted of 269 individuals from 127 families, for a total of 159 affected sib pairs (114 sibships with 2 affected, 11 sibships with 3 affected, and 2 sibships with 4 affected). Parental affection status of these subjects is unknown. The average age for the Dresden/Chicago groups at the time of study was 59.2 ± 9.4/55.6 ± 12.4 years (mean ± SD) and at diagnosis was 44.9 ± 10.0/47.2 ± 12.4 years. The duration of NIDDM was 14.5 ± 7.9/8.6 ± 7.8 years and BMI was 28.5 ± 4.9/32.4 ± 7.8 kg/m 2 . Treatment was 9.0/19.1% with diet, 38.0/36.8% with oral hypoglycemic agents, 51.5/44.4% with insulin, and 1.5/0% unknown. Population differences were tested by Student's t test, assuming unequal variances with 2 df (age at time of study, P < 0.028; age at diagnosis, not significant; duration of diabetes, P < 0.0000007; and BMI, P < 0.0005).
The yeast artificial chromosome (YAC) address for TUB, the human homolog of the murine obesity gene tubby, was determined by screening YAC pools (Research Genetics, Huntsville, AL) with the primers TubF, 5'-TTTGCCATTGCC-CTGTCCAGCTTC-3', and TubR, 5' -CAAAGGAGCCAGTTC-CTGGCTGGC-3', as described previously (11) . TUB was mapped and confirmed to YACs 954F4 and 960F10. These YACs included the simple tandem repeat polymorphism (STRP) D11S932. The Genethon Human Genetic Linkage Map 1996 indicated that D11S4049 mapped to the same position and this marker was used for linkage studies because of its higher polymorphism information content (PIC) value (12) .
Genotyping with the simple-sequence repeat polymorphisms D11S1338, D11S4149, D11S1349, D11S921, D11S928, D11S1359, D11S929, and D11S914 (Research Genetics) was carried out, as described previously (6) .
Markers were tested for linkage, as described previously, using the computer programs AFFSIB (13), SPLINK (14, 15) , and GENEHUNTER (16; modified by A. Kong, N.J.C., unpublished observations); all families were weighted equally, regardless of the number of affected sibs. Marker allele frequencies were estimated from the data using SPLINK. To insure that heterogeneity between the American and German samples did not affect the results, the two groups were analyzed separately as well as in a pooled Caucasian sample.
Eight STRPs spanning a 31-cM region of chromosome 11 were tested for linkage with NIDDM in a combined group of 159 non-Hispanic affected sib pairs. There was no evidence of linkage (i.e., P < 0.05) of any of these markers with NIDDM using any of the tests described above; the results of the multipoint analysis using the program GENEHUNTER are shown in Fig. 1 . The results were similar whether each study group was analyzed independently or combined, suggesting that even when differences in ethnic background were present in the Dresden/Chicago samples, they did not confound the analysis. The marker D11S1359 almost reaches the threshold for nominal evidence for linkage (i.e., P < 0.05) with a value of the maximum likelihood score (MLS) (SPLINK) of 0.62 (P = 0.06).
The multipoint results provide no compelling evidence for linkage of markers for TUB (D11S4149) or SUR1/Kir6.2 (D11S921) with NIDDM, excluding these as major susceptibility genes in this group of non-Hispanic whites.
The multipoint analyses permit us to quantify the possible effect of loci from this region on NIDDM susceptibility.
The highest multipoint logarithm of odds (LOD) score is in the region of D11S1359, not TUB or SUR1/Kir6.2, and the magnitude of its effect can be quantified based on the locusspecific X s value (17) , which for D11S1359 is 1.18. Assuming a total X s of 3.5 for NIDDM (18) and a multiplicative model, a susceptibility locus from this region accounts for <10% of the familial clustering of NIDDM. The results presented in Fig. 1 indicate that TUB and SUR1/Kir6.2 would have an even smaller effect. Loci with \ s of > 2.8 can be excluded from this region (LOD scores -2.0 or less).
In summary, the results provide little evidence for linkage of SURllKir6.2 or TUB with NIDDM. The strongest evidence for linkage, albeit nonsignificant, was at D11S1359, ~1 cM from D11S899, which had a maximum LOD score of 3.37, with 2-h glucose concentration in Mexican-Americans (20) . If there is a diabetes susceptibility locus in this region, it is likely to account for only a small portion of the total liability to NIDDM in this non-Hispanic white population. The major loci contributing to NIDDM susceptibility in this population remain to be determined.
